DI LORENZO, ANTONINO
 Distribuzione geografica
Continente #
EU - Europa 212
NA - Nord America 193
AS - Asia 142
OC - Oceania 4
Totale 551
Nazione #
US - Stati Uniti d'America 186
IT - Italia 124
CN - Cina 67
SG - Singapore 41
IE - Irlanda 28
SE - Svezia 15
DE - Germania 12
KR - Corea 8
IN - India 7
BE - Belgio 6
FI - Finlandia 6
ID - Indonesia 6
GB - Regno Unito 5
HK - Hong Kong 5
AU - Australia 4
FR - Francia 4
RU - Federazione Russa 4
VN - Vietnam 4
CA - Canada 3
MX - Messico 3
CH - Svizzera 2
GR - Grecia 2
JP - Giappone 2
AT - Austria 1
CU - Cuba 1
MO - Macao, regione amministrativa speciale della Cina 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
UA - Ucraina 1
Totale 551
Città #
Turin 47
Singapore 34
Chandler 27
Dublin 27
Santa Clara 22
Torino 15
Nyköping 10
Houston 9
Fairfield 8
Beijing 7
Ashburn 6
Cambridge 6
Guangzhou 6
Jakarta 6
Monza 6
Chieri 5
Hangzhou 5
Parma 5
Columbus 4
Helsinki 4
Jacksonville 4
Milan 4
Nanjing 4
Woodbridge 4
Chengdu 3
Chennai 3
Darmstadt 3
Evanston 3
Falkenstein 3
Ghent 3
Hyderabad 3
Lake Odessa 3
Padova 3
Princeton 3
Seattle 3
Shanghai 3
Villa Bartolomea 3
Wilmington 3
Zhengzhou 3
Alessandria 2
Ann Arbor 2
Athens 2
Boston 2
Chicago 2
Ixelles-Elsene 2
Lappeenranta 2
Medford 2
Moscow 2
Munich 2
Münster 2
New York 2
Ottawa 2
Redwood City 2
Rolle 2
Seoul 2
Strasbourg 2
Wuhan 2
Xian 2
Ahome 1
Blaise 1
Boardman 1
Brussels 1
Casalnuovo Di Napoli 1
Castelletto Stura 1
Central District 1
Changsha 1
Chongqing 1
Civita Castellana 1
Fairfax 1
Florence 1
Fuzhou 1
Galway 1
Glasgow 1
Glen Burnie 1
Grugliasco 1
Guiyang 1
Hebei 1
Horjul 1
Huzhou 1
Jena 1
La Habana 1
London 1
Los Angeles 1
Mechanicsville 1
Meguro-ku 1
Montréal 1
Nanning 1
Napoli 1
New Brunswick 1
Nuremberg 1
Ortignano Raggiolo 1
Pisa 1
Pittsburgh 1
Pusan 1
Rivoli 1
Rome 1
San Diego 1
San Mateo 1
Silver Spring 1
Toluca 1
Totale 400
Nome #
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer 219
Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota 100
Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy? 62
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy 50
A Magnetic Resonance Imaging‐Chemical Exchange Saturation Transfer (MRI‐CEST) Method for the Detection of Water Cycling across Cellular Membranes 46
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment 37
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models 29
Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease 26
Cross-Reactive Immune Response of Bovine Coronavirus Spike Glycoprotein to SARS-CoV-2 Variants of Concern 1
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes? 1
Totale 571
Categoria #
all - tutte 2.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.220


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 0 20 5 13 16 27 19
2021/202295 19 6 5 5 5 8 6 5 4 9 9 14
2022/2023149 9 9 2 9 18 41 25 7 12 3 9 5
2023/2024101 16 15 6 5 6 4 7 15 0 9 9 9
2024/2025126 12 11 15 13 46 29 0 0 0 0 0 0
Totale 571